291P Trastuzumab emtansine in HER2-positive metastatic breast cancer after pertuzumab and trastuzumab: TDM1RM Study

Autor:	Maria Isabel Luengo, P. Sanchez Henarejos, F. Ayala de la Peña, R. Carrillo Vicente, Eulogio García, P de la Morena Barrio, T. Quiros, E. Garcia Garre, Alejandro López, Gema Marín, D. Collado, E. Garcia Torralba, J. Balsalobre, José Luis Alonso Romero, J.C. Martínez-García, M.D. Jimenez Lucas, M.J. Martinez Ortiz, A. Puertes Boix, A. Sanchez Saura, D.A. Sánchez
Rok vydání:	2020
Předmět:	Oncology medicine.medical_specialty business.industry Hematology medicine.disease Metastatic breast cancer chemistry.chemical_compound chemistry Trastuzumab Trastuzumab emtansine Internal medicine medicine Pertuzumab business medicine.drug
Zdroj:	Annals of Oncology. 31:S358
ISSN:	0923-7534
DOI:	10.1016/j.annonc.2020.08.393
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::6b9bdaf2340f4db799c5c9f562798c49 https://doi.org/10.1016/j.annonc.2020.08.393 Zobrazit plný text záznamu